1. Jay Frame Jay Frame United States says:

    As of September 2011, Soliris is the only therapy approved for the treatment of atypical hemolytic uremic syndrome (aHUS): news.alexionpharma.com/.../soliris-eculizumab-approved-fda-all-patients-atypical-hemolytic-uremic-sy

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.